Universal Ibogaine Stock Market Value
| IBOGF Stock | USD 0 0.0002 4.44% |
| Symbol | Universal |
Universal Ibogaine 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Universal Ibogaine's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Universal Ibogaine.
| 12/16/2025 |
| 01/15/2026 |
If you would invest 0.00 in Universal Ibogaine on December 16, 2025 and sell it all today you would earn a total of 0.00 from holding Universal Ibogaine or generate 0.0% return on investment in Universal Ibogaine over 30 days. Universal Ibogaine is related to or competes with Ayala Pharmaceuticals. Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada More
Universal Ibogaine Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Universal Ibogaine's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Universal Ibogaine upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 22.19 | |||
| Information Ratio | 0.0734 | |||
| Maximum Drawdown | 105.56 | |||
| Value At Risk | (29.58) | |||
| Potential Upside | 38.0 |
Universal Ibogaine Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Universal Ibogaine's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Universal Ibogaine's standard deviation. In reality, there are many statistical measures that can use Universal Ibogaine historical prices to predict the future Universal Ibogaine's volatility.| Risk Adjusted Performance | 0.0653 | |||
| Jensen Alpha | 1.81 | |||
| Total Risk Alpha | (1.75) | |||
| Sortino Ratio | 0.0745 | |||
| Treynor Ratio | (4.14) |
Universal Ibogaine Backtested Returns
Universal Ibogaine is out of control given 3 months investment horizon. Universal Ibogaine owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0864, which indicates the firm had a 0.0864 % return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.99% are justified by taking the suggested risk. Use Universal Ibogaine Coefficient Of Variation of 1269.63, semi deviation of 18.19, and Risk Adjusted Performance of 0.0653 to evaluate company specific risk that cannot be diversified away. Universal Ibogaine holds a performance score of 6 on a scale of zero to a hundred. The entity has a beta of -0.43, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Universal Ibogaine are expected to decrease at a much lower rate. During the bear market, Universal Ibogaine is likely to outperform the market. Use Universal Ibogaine jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to analyze future returns on Universal Ibogaine.
Auto-correlation | -0.04 |
Very weak reverse predictability
Universal Ibogaine has very weak reverse predictability. Overlapping area represents the amount of predictability between Universal Ibogaine time series from 16th of December 2025 to 31st of December 2025 and 31st of December 2025 to 15th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Universal Ibogaine price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current Universal Ibogaine price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.04 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Universal Ibogaine lagged returns against current returns
Autocorrelation, which is Universal Ibogaine pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Universal Ibogaine's pink sheet expected returns. We can calculate the autocorrelation of Universal Ibogaine returns to help us make a trade decision. For example, suppose you find that Universal Ibogaine has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Universal Ibogaine regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Universal Ibogaine pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Universal Ibogaine pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Universal Ibogaine pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Universal Ibogaine Lagged Returns
When evaluating Universal Ibogaine's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Universal Ibogaine pink sheet have on its future price. Universal Ibogaine autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Universal Ibogaine autocorrelation shows the relationship between Universal Ibogaine pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Universal Ibogaine.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Universal Pink Sheet
Universal Ibogaine financial ratios help investors to determine whether Universal Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Universal with respect to the benefits of owning Universal Ibogaine security.